Suppr超能文献

推进比较有效性研究方法的 CTSA 议程。

A CTSA agenda to advance methods for comparative effectiveness research.

机构信息

Oregon Clinical & Translational Research Center, Oregon Health & Sciences University, and Department of Hospital and Specialty Medicine, The Portland VA Medical Center, Portland, OR, USA.

出版信息

Clin Transl Sci. 2011 Jun;4(3):188-98. doi: 10.1111/j.1752-8062.2011.00282.x.

Abstract

Clinical research needs to be more useful to patients, clinicians, and other decision makers. To meet this need, more research should focus on patient-centered outcomes, compare viable alternatives, and be responsive to individual patients' preferences, needs, pathobiology, settings, and values. These features, which make comparative effectiveness research (CER) fundamentally patient-centered, challenge researchers to adopt or develop methods that improve the timeliness, relevance, and practical application of clinical studies. In this paper, we describe 10 priority areas that address 3 critical needs for research on patient-centered outcomes (PCOR): (1) developing and testing trustworthy methods to identify and prioritize important questions for research; (2) improving the design, conduct, and analysis of clinical research studies; and (3) linking the process and outcomes of actual practice to priorities for research on patient-centered outcomes. We argue that the National Institutes of Health, through its clinical and translational research program, should accelerate the development and refinement of methods for CER by linking a program of methods research to the broader portfolio of large, prospective clinical and health system studies it supports. Insights generated by this work should be of enormous value to PCORI and to the broad range of organizations that will be funding and implementing CER.

摘要

临床研究需要对患者、临床医生和其他决策者更加有用。为了满足这一需求,更多的研究应该侧重于以患者为中心的结果,比较可行的替代方案,并对个体患者的偏好、需求、病理生物学、环境和价值观做出回应。这些使比较效果研究(CER)从根本上以患者为中心的特点,要求研究人员采用或开发能够提高临床研究的及时性、相关性和实际应用的方法。在本文中,我们描述了 10 个优先领域,这些领域针对以患者为中心的结果研究的 3 个关键需求:(1)开发和测试可靠的方法,以确定和优先考虑研究的重要问题;(2)改进临床研究的设计、实施和分析;(3)将实际实践的过程和结果与以患者为中心的结果研究的优先事项联系起来。我们认为,美国国立卫生研究院(NIH)应该通过其临床和转化研究计划,通过将方法研究计划与它支持的大型前瞻性临床和卫生系统研究的更广泛组合联系起来,加速 CER 方法的开发和完善。这项工作产生的见解对 PCORI 和将资助和实施 CER 的广泛组织将具有巨大价值。

相似文献

6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

3
MIFuzzy Clustering for Incomplete Longitudinal Data in Smart Health.智能健康中不完整纵向数据的MIFuzzy聚类
Smart Health (Amst). 2017 Jun;1-2:50-65. doi: 10.1016/j.smhl.2017.04.002. Epub 2017 Apr 27.
9
The patient is in: patient involvement strategies for diagnostic error mitigation.患者处于:参与策略可减轻诊断错误。
BMJ Qual Saf. 2013 Oct;22 Suppl 2(Suppl 2):ii33-ii39. doi: 10.1136/bmjqs-2012-001623. Epub 2013 Jul 26.

本文引用的文献

5
The role of costs in comparative effectiveness research.成本在比较效果研究中的作用。
Health Aff (Millwood). 2010 Oct;29(10):1805-11. doi: 10.1377/hlthaff.2010.0647.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验